Open AccessEfficacy of infliximab in acute severe ulcerative colitis: A single-centre experience
Author(s) -
Stephen Halpin,
P. J. Hamlin,
Daniel P. Greer,
Lorraine Warren,
Alexander C Ford
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i7.1091
Subject(s) - medicine , ulcerative colitis , infliximab , colectomy , thiopurine methyltransferase , interquartile range , clinical endpoint , adverse effect , gastroenterology , surgery , inflammatory bowel disease , randomized controlled trial , disease
To suggest infliximab (IFX) is effective for acute severe ulcerative colitis, from real-life clinical practice.